PET examinations utilizing PSMA ligands labeled with 68Ga or 18F, both highly effective nuclear imaging tracers, offer the capability to analyze the distribution of cancer cells in the body, particularly in prostate cancer. The gene discussed is FOLH1; the disease is prostate carcinoma.